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Sonic Hedgehog Induces the Segregation
of Patched and Smoothened in Endosomes
proteins, Ptc, a polytopic protein with 12 transmem-
brane segments, and Smo, which is related to G protein-
coupled receptors [2]. Combined genetic and biochemi-
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Sciences II Ptc and Smo interact directly to form a receptor complex
University of Geneva that remains associated after ligand binding [3, 6, 7].
1211-Geneva-4 These data led to the prevailing model for Hh signal
Switzerland transduction in which the regulation of Smo activity by
Ptc involves ligand-induced conformational changes
within a nondissociating Ptc/Smo receptor complex [8].
Summary Ptc also plays a second, genetically separable role in
Hh signaling. Upregulation of Ptc synthesis is an early
Background: Sonic hedgehog (Shh) signal transduc- response to Hh signaling that acts to sequester Hh and
tion involves the ligand binding Patched1 (Ptc1) protein limit its range of transport within tissues [9]. Any model
and a signaling component, Smoothened (Smo). A select for Ptc function must account for both of these activities.
group of compounds inhibits both Shh signaling, regu- Recent studies on the distributions of Ptc and Smo
lated by Ptc1, and late endosomal lipid sorting, regu- in Drosophila appear to conflict with the above model
lated by the Ptc-related Niemann-Pick C1 (NPC1) pro- and instead suggest that the Ptc/Smo relationship may
tein. This suggests that Ptc1 regulates Smo activity be nonstoichiometric and indirect [10, 11]. Two studies
through a common late endosomal sorting pathway also suggest that Ptc acts to destabilize Smo protein [10,
utilized by NPC1. During signaling, Ptc accumulates in 12]. In the most detailed study [10], the distributions of
endosomal compartments, but it is unclear if Smo fol- Ptc and Smo were analyzed biochemically in cultured
lows Ptc into the endocytic pathway. cell lines that respond to exogenous Hh and morphologi-
Results: We characterized the dynamic subcellular dis- cally in the developing wing imaginal disc where endog-
tributions of Ptc1, Smo, and activated Smo mutants enous Hh signaling occurs. Hh treatment of cell lines
individually and in combination. Ptc1 and Smo colocal- resulted in the removal of Ptc from the cell surface with
ize extensively in the absence of ligand and are internal- subsequent accumulation of Smo at the cell surface in
ized together after ligand binding, but Smo becomes a highly phosphorylated form [10]. In wing disc cells that
segregated from Ptc1/Shh complexes destined for lyso- have already responded to Hh, Ptc appeared predomi-
somal degradation. In contrast, activated Smo mutants nantly in characteristic vesicles that were concentrated
do not colocalize with nor are cotransported with Ptc1. apically in these polarized epithelial cells, while Smo
Agents that block late endosomal transport and protein was distributed basolaterally [10]. Finally, evidence of
sorting inhibit the ligand-induced segregation of Ptc1 immunoprecipitable Ptc/Smo complexes derived from
and Smo. We show that, like NPC1-regulated lipid sort- Drosophila tissues is lacking [13].
ing, Shh signal transduction is blocked by antibodies
Several observations suggest that the mechanism by
that specifically disrupt the internal membranes of late
which Ptc controls Smo signaling involves vesicular
endosomes, which provide a platform for protein and
transport. First, extensive structural similarity is shared
lipid sorting.
between Ptc proteins (Ptc1 and Ptc2 in vertebrates) andConclusions: These data support a model in which Ptc1
the Niemann-Pick C1 (NPC1) protein, which includesinhibits Smo only when in the same compartment. Li-
but is not limited to the sterol-sensing domain (SSD)gand-induced segregation allows Smo to signal inde-
[14, 15]. NPC1 functions in the sorting and recycling ofpendently of Ptc1 after becoming sorted from Ptc1/Shh
cholesterol and glycosphingolipids in the late endoso-complexes in the late endocytic pathway.
mal/lysosomal system [16]. NPC1 and Ptc1 colocalized
extensively in transfected cells [17]; Ptc1 functions inIntroduction
the receptor-mediated endocytosis of Hh proteins [18],
and Ptc vesicles observed in Drosophila include multi-Members of the hedgehog (Hh) family of morphogens
vesicular late endosomes [19]. Second, a diverse groupplay key roles in patterning diverse tissues during devel-
of steroidal compounds and hydrophobic amines inhib-opment. Shh is essential for inducing the formation of
its both Shh signaling, regulated by Ptc1, and vesicularventral cell types in the vertebrate neural tube [1]. Initial
transport of intracellular cholesterol, regulated by NPC1events in Hh signal transduction involve at least two
[20]. Third, mutations in the SSD of Drosophila Ptc ren-
der the protein incapable of inhibiting Smo [21, 22].
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ery, is required for negative regulation of Shh signaling (Figure 1C) and presence (Figure 1G) of ligand. Similarly,
incubation of cells with concanamycin A, a specific vac-in the vertebrate neural tube [24].
Several key issues are left unresolved by the studies uolar H/ATPase inhibitor that blocks transport out of
early endosomal compartments [29, 30], protected Ptc1described above. Among these, what are the subcellular
distributions of Ptc and Smo in cells prior to ligand from degradation (Figures 1D and 1H). ShhN internalized
by Ptc1 accumulated to much higher levels with leupep-exposure? What happens to Ptc and Smo between initial
exposure to ligand, activation of signal transduction, tin treatment (Figures 1J and 1K), consistent with obser-
vations on endogenous Shh in embryonic neural tissueand upregulation of Ptc expression? Does Smo follow
Ptc into the endocytic pathway? Does Ptc possess an [18]. These findings indicate that Ptc1 is constitutively
transported to lysosomes and degraded, and that ligandintrinsic activity that destabilizes or modifies Smo? Do
Ptc and Smo form a complex when not expressed by binding significantly enhances its lysosomal degra-
dation.transient overexpression? To address these issues, we
characterized the dynamic distributions of Ptc1, Smo, The route of Ptc1 transport was confirmed with mark-
ers of endocytic compartments. Leupeptin treatmentand Smo mutants (SmoM1 and SmoM2) that are not
inhibited by Ptc1 [7, 25] in cell lines expressing the pro- alone dramatically increased Ptc1 late endosomes/
lysosomes marked by lysosome-associated membraneteins at low levels, alone and in combination. We find
that Ptc1 and Smo colocalize extensively prior to Shh glycoprotein-1 (LAMP-1; Figures 1L and 1M). In the ab-
sence of leupeptin, the small amount of internalizedexposure and undergo cotransport into the endosomal
system after ligand binding. Although we could not de- ShhN detected was localized to LBPA late endosomes
(Figure 1P), and, in the presence of leupeptin, ShhN andtect Ptc1/Smo complexes by immunoprecipitation, the
activated Smo mutants neither colocalized nor were co- Ptc1 accumulated highly in LAMP-1 vesicles (Figures
1N and 1O). Double labeling for Ptc1 and LBPA wastransported with Ptc1. After entry into endosomes, Smo
was subsequently segregated from Ptc1/Shh com- precluded by a requirement for Triton X-100 permeabili-
zation to expose Ptc1HA immunoreactivity, which ex-plexes destined for degradation. Consistent with this,
Shh signaling is inhibited by antibodies against the late tracts LBPA. Concanamycin A treatment resulted in the
accumulation of Ptc1 and ShhN in transferrin early en-endosome-specific lipid lysobisphosphatidic acid (LBPA),
which is localized to the internal membranes of late dosomes (Figures 1Q and 1R), and ShhN did not colocal-
ize with LBPA (data not shown). Ptc1 early endosomesendosomes and provides a platform for protein and lipid
sorting [26–28]. These data support a model in which appeared with similar kinetics (data not shown) and de-
gree with or without ligand, indicating that Ptc1 reachesactive Smo accumulates in a ligand-dependent manner
after being segregated from Ptc/Shh complexes in the endosomes from the cell surface rather than by another
route.late endocytic pathway.
Results In the Absence of Ptc1, Smo Accumulates at the
Cell Surface and in Early Endosomal Compartments
Since satisfactory reagents are unavailable for analysis Smo was detected on the cell surface (Figure 2A, green)
of endogenous Ptc1 and Smo, we generated KNRK cell and in juxtanuclear and peripheral vesicular structures
lines stably expressing various levels of hemaggluti- (Figure 2A, red). Internalization of Smo N-terminal anti-
nin(HA)-tagged Ptc1 (“Ptc1HA cells”), Smo tagged with bodies by live cells resulted in the labeling of structures
a glycoprotein D (gD) epitope at the N terminus and/or indistinguishable from those labeled by C-terminal anti-
a Flag epitope at the C terminus (“gD-SmoF cells or Flag in fixed, permeabilized cells (Figure 2B), suggesting
“SmoF cells”), and two gD-tagged mutants, SmoM1 and that intracellular Smo is derived by endocytosis. Treat-
SmoM2 (see the Experimental Procedures in the Supple- ment with brefeldin A resulted in significant intensifica-
mentary Material available with this article online). To tion of Smo juxtanuclear immunofluorescence, even
assess any direct effects that Ptc1 and Smo may have after prolonged cycloheximide treatment (Figures 2C
on each other, we first characterized the subcellular and 2D). Brefeldin A produces dramatic morphologic
distributions of each protein alone, then in combination. effects on both the TGN and early/recycling endosomes
(containing the transferrin receptor) in NRK cells, caus-
ing these organelles to cluster around the microtubule-In the Absence of Smo, Ptc1 Undergoes Constitutive
Internalization and Transport to Late organizing center [31]. However, in contrast to Ptc1 (see
the Supplementary Material), juxtanuclear Smo showedEndosomes/Lysosomes
Ptc1 was associated largely with juxtanuclear structures no colocalization with the TGN marker TGN38 (Figure
3G) and instead colocalized with the transferrin receptor(Figure 1A) including mannose-6-phosphate receptor
late endosomes and the trans-Golgi network (TGN) (see (Figure 2E). Finally, Smo did not colocalize with LBPA
or LAMP-1 late endosomes/lysosomes (Figures 2F andthe Supplementary Material available with this article
online). The half-life of Ptc1 was short, with loss of an 2G), even in the presence of leupeptin (Figure 2H).
Treatment of cells with chloroquine showed furtherimmunofluorescent signal (Figures 1A and 1B) and pro-
tein levels (Figure 1I, lanes 1 and 3) within 4–6 hr of differences between the distributions of Ptc1 and Smo.
Chloroquine blocks recycling from the endocytic path-cycloheximide treatment. ShhN treatment reduced Ptc1
levels even further (Figures 1E, 1F, and 1I, lanes 2 and way and was used previously to demonstrate that
TGN38 rapidly cycles continuously between the cell sur-4). Cellular uptake of the lysosomal protease inhibitor
leupeptin extended Ptc1 half-life both in the absence face and TGN via endosomes [32, 33]. Ptc1 appeared
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Figure 1. Ptc1 Undergoes Ligand-Independent Transport to Late Endosomes, and Its Lysosomal Degradation Is Enhanced by Shh
(A–H) Ptc1 immunofluorescence in permeabilized Ptc1HA cells. (A) Untreated cells. (B) Cycloheximide, 6 hr. (C) Cycloheximide and 1 mM
leupeptin, 6 hr. (D) Cycloheximide and 100 nM concanamycin A, 6 hr. (E) ShhN, 4 hr. (F) Cycloheximide, 2 hr; followed by ShhN, 4 hr. (G)
Cycloheximide, 1 hr; followed by 1 mM leupeptin, 1 hr; then ShhN, 4 hr. (H) Cycloheximide, 1 hr; followed by 100 nM concanamycin A, 1 hr;
then ShhN, 4 hr.
(I) Western blot analysis of Ptc1HA levels after cycloheximide and ShhN treatment as described for (A), (B), (E), and (F) above. Lanes 1–4
represent the same clone shown in (A)–(H), while lanes 5–6 represent a clone with lower expression. Lanes were loaded with equivalent total
protein.
(J–K) Shh immunofluorescence in Ptc1HA cells incubated for 4 hr in (J) ShhN alone or (K) 1 mM leupeptin and ShhN.
(L–N) Cells double labeled for Ptc1 (green) and LAMP-1 (red). (L) Untreated cell. (M) 1 mM leupeptin, 6 hr. (N) leupeptin, 3 hr; followed by
ShhN, 3 hr. Arrowheads in (M) and (N) indicate individuals or clusters of Ptc1/LAMP-1 vesicles.
(O) Cell double labeled for Ptc1 (green) and Shh (red) after incubation with 1 mM leupeptin and ShhN for 5 hr.
(P) Cell double-labeled for Shh (green) and LBPA (red) after incubation with ShhN for 4 hr.
(Q) A cell labeled for Ptc1 (green) after incubation with Texas red-conjugated transferrin (Tf-TR, red) for 1 hr, followed by 100 nM concanamycin
A and 4 hr of further incubation. Arrowheads indicate Ptc1/Tf-TR early endosomes.
(R) Ptc1 (green) and Shh (red) immunofluorescence in a cell incubated in concanamycin A for 1 hr, followed by the addition of ShhN and 4
hr of further incubation. Arrowheads indicate Ptc1/Shh early endosomes. ShhN concentration was 2 nM for all experiments. chx, cyclohexi-
mide; cna, concanamycin A; leu, leupeptin.
The scale bars represent 25 m in (A)–(H), (J), and (K) and 10 m in (L)–(R).
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Figure 2. Smo Is Distributed at the Cell Surface and in Early Endoso-
mal Compartments
(A) SmoF cell labeled with antibodies against the Smo extracellular
domain (SmoN; green) prior to permeabilization, followed by labeling
with anti-Flag antibody (red).
(B) A cell incubated for 2 hr at 37C with 10g/ml anti-SmoN antibod-
ies, followed by fixation, permeabilization, and detection of internal-
ized antibodies.
(C) Smo immunofluorescence after 4 hr brefeldin A treatment.
(D) Smo immunofluorescence after treatment with cycloheximide
for 2 hr, followed by brefeldin A for 4 hr.
(E) A cell labeled for Smo (green) after incubation in Texas red-
conjugated transferrin (Tf-TR; red); colocalization is shown as
Figure 3. Effects of Chloroquine on the Distributions of Ptc1 andyellow.
Smo(F) A cell double labeled for Smo (green) and LBPA (red).
(G–H) Cells double labeled for Smo (green) and LAMP-1 (red) (G) (A–L) Ptc1HA and SmoF cells were incubated with cycloheximide
without and (H) after incubation for 6 hr in 1 mM leupeptin. and 100 M chloroquine, fixed at 30-min intervals, and analyzed for
Scale bars represent 10 m. bfa, brefeldin A; chx, cycloheximide. Ptc1 or Smo (green) and TGN38 (red) immunofluorescence. Colocali-
zation is seen as yellow/orange. Unfilled arrowheads indicate Ptc1/
TGN38 vesicles; filled arrowheads indicate Ptc1/TGN38 vesicles.
The scale bars represent 10 m.in endosomes marked with fluid-phase tracer (data not
shown) within 30–60 min of chloroquine addition (Fig-
ures 3B and 3C), prior to the appearance of TGN38 in
endosomes. By 90 min, Ptc1 and TGN38 colocalized 3E and 3F). In contrast, while TGN38 accumulated in
endosomes, chloroquine had little effect on the distribu-extensively in endosomes (Figure 3D). The size and num-
ber of Ptc1/TGN38 vesicles gradually increased and tion of Smo (Figures 3G–3L). However, after 6 hr in chlo-
roquine, large, ring-shaped Smo vesicular structureswere maximal between 2 and 3 hr of treatment (Figures
Shh Induces the Segregation of Ptc and Smo
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Figure 4. Smo Mutants Have Distributions
Distinct from Wild-Type Smo
(A–I) Uncloned populations of cells stably ex-
pressing gD-SmoF (wt), gD-SmoM1, and gD-
SmoM2 were treated with (A–C) solvent, (D–F)
5 g/ml brefeldin A, or (G–I) 100 M chlo-
roquine for 6 hr, fixed, permeabilized, and
analyzed by immunofluorescence with anti-
gD antibodies. The altered morphology of
SmoM2 immunofluorescence with (I) chlo-
roquine treatment appears to be a conse-
quence of the displacement of ER elements
by large swollen endocytic vesicles. The
scale bars represent 10 m.
were observed (Figure 4). Therefore, Smo either under- (Figure 4F). Since brefeldin A also blocks ER-to-Golgi
transport, this finding is consistent with localization ofgoes much slower internalization than Ptc1 or is sorted
from the endocytic pathway at a relatively chloroquine- SmoM2 to the ER. In contrast, brefeldin treatment re-
sulted in an intensification of the juxtanuclear compo-insensitive step. ShhN had no effect on Smo distribution
(data not shown). Shh had no influence on the kinetics nent of SmoM1 immunofluorescence (Figure 4E), but to
a smaller degree than wtSmo (Figure 4D). While a 6-hrwith which Ptc1 vesicles appeared in chloroquine-
treated cells, and the colocalization of Ptc and Shh in chloroquine treatment resulted in the appearance of
wtSmo in large, swollen vesicular structures (Figure 4G),these vesicles was retained (data not shown). These
results confirm that Ptc1 reaches endosomes via the cell SmoM2 retained its ER distribution (Figure 4I). SmoM1
showed a distribution intermediate to wtSmo andsurface rather than by a direct Golgi-endosome route,
consistent with the effects of concanamycin A. SmoM2 after chloroquine treatment (Figure 4H), with a
smaller fraction appearing in swollen vesicles in addition
to a large ER component.Activated Smo Mutants Have Distinct Subcellular
Distributions
Two activated Smo mutants, SmoM1 and SmoM2, were
When Coexpressed, Ptc1 and Smo Undergoisolated from human basal cell carcinomas [25] and are
Simultaneous Ligand-Induced Internalizationresistant to Ptc1 inhibition [7]. M1 represents a change
but Are Subsequently Segregatedof Arg562 to Gln in the cytoplasmic tail and was 50%
in the Endocytic Pathwayinhibited by Ptc1 coexpression, while M2 represents a
Since biosynthetic and endocytic organelles mix homo-change of Trp535 to Leu in the seventh transmembrane
typically in hybrid cells [34–36], we analyzed the distribu-segment and was uninhibited by Ptc1 [7]. The distribu-
tions of Ptc1 and Smo after fusion of Ptc1HA cells withtion of SmoM2 differed most significantly from wild-type
SmoF cells. This allowed us to determine the effects ofSmo (wtSmo) (Figure 4C), appearing in a pattern virtually
Ptc1 and Smo on each other when expressed at theidentical to an ER marker (data not shown). SmoM2
same levels for which we characterized each individu-was conspicuously absent from the juxtanuclear region,
ally. Within several hours after fusion, Ptc1 and Smowhere most of the intracellular wtSmo resides. In con-
colocalized diffusely in the juxtanuclear region and pe-trast, SmoM1 showed a distribution that appeared to
ripheral punctate structures (Figure 5A), overall showingbe a combination of the wtSmo and SmoM2 patterns
about 90% colocalization (Figure 5R). Ptc1 and Smo(Figure 4B), with SmoM1 juxtanuclear structures super-
retained extensive colocalization after the dispersal ofimposed on the ER pattern. Analysis of the effects of
juxtanuclear structures with nocodazole (data not shown),brefeldin A and chloroquine also showed significant dif-
but the immunofluorescence was more diffuse than inferences in the transport of Smo mutants. Brefeldin A
treatment had no effect on the distribution of SmoM2 cells expressing Ptc1 alone (see the Supplementary Ma-
Current Biology
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Figure 5. Trafficking of Ptc1 Is Altered in the Presence of Smo, and Both Proteins Are Internalized in Response to Ligand but Subsequently
Are Segregated
A confluent mixture of Ptc1HA and SmoF cells were fused, allowed to recover for 5 hr, then incubated either with 100 M chloroquine in the
(B–F) absence and (G–K) presence of 2 nM ShhN, or 1 mM leupeptin for 1 hr, followed by the addition of (M–Q) 2 nM ShhN, then fixed at 30-
min or 1-hr intervals and analyzed for Ptc1 (green) and Smo (red) immunfluorescence. Colocalization is shown as yellow/orange, and time
points in minutes are at the left.
(A) An untreated hybrid cell double labeled for Ptc1 and Smo 8 hr after fusion. The cell has three nuclei (N).
(B–F) Chloroquine-treated cells. Arrowheads indicate Ptc1/Smo endosomes.
(G–K) Cells treated with chloroquine and ShhN. Arrowheads indicate Ptc1/Smo endosomes.
(L) A hybrid cell incubated for 4 hr in leupeptin alone.
(M–Q) Hybrid cells incubated in leupeptin and 2 nM ShhN. The scale bars represent 10 m.
(R) Colocalization of Ptc and Smo was quantified in a series of confocal images for which (A)–(Q) are representative. Values are the average
percent colocalization and SEM measured as the area of overlap between Ptc1 and Smo immunofluorescence. The number of hybrid cells
measured is indicated above the error bars.
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terial), probably due to an increased presence of Ptc1 tially no colocalization of Ptc1 and SmoM2 (Figure 6C).
and Smo in the early Golgi and/or ER. SmoM2 localized to ER-like structures throughout the
To determine if Ptc1 and Smo entered endosomes cytoplasm and was notably absent from the juxtanuclear
together, cells were treated with chloroquine as in Figure region to which Ptc1 localized. In contrast, SmoM1 and
3. Strikingly, when combined with Smo, Ptc1 did not Ptc1 colocalized to some degree in diffuse juxtanuclear
enter endosomes with rapid kinetics (Figures 5B–5F), structures (Figure 6B), similar to Ptc1 and wtSmo (Figure
as it did when expressed alone (Figures 3B–3F). Only a 6A), but a significant fraction of SmoM1 also localized
few Ptc1/Smo vesicular structures were observed throughout the cytoplasm. Treatment of hybrid cells with
after 3 hr in chloroquine (Figure 5E). By 6 hr, most hybrid chloroquine for 90 min showed significant differences
cells had several ring-shaped Ptc1/Smo vesicles (Fig- in the distribution of Ptc1 in the presence of the three
ure 5F), similar to cells expressing Smo alone. When Smo proteins. While Ptc1 did not appear in vesicles
chloroquine was combined with ShhN (Figures 5G–5K), when combined with wtSmo (Figures 5 and 6D), in the
Ptc1/Smo endosomes appeared within 30 min (Figure presence of SmoM2, numerous Ptc1/SmoM2 vesicles
5G). Double-positive vesicles significantly increased in were apparent (Figure 6F), similar to cells expressing
number by 3 hr (Figure 5J) and were larger and ring- Ptc1 alone (Figure 3D). Ptc1 and SmoM1 colocalized
shaped by 6 hr (Figure 5K). Despite the dramatic redistri- significantly in juxtanuclear structures after chloroquine
bution in response to ligand, Ptc1 and Smo remained treatment (Figure 6E), similar to Ptc1 and wtSmo, but
extensively colocalized over the entire time course (Fig- there was generally a slightly higher degree of a more
ure 5R). In similar experiments, Ptc1 and Smo accumu- punctate Ptc1 signal that did not colocalize with SmoM1.
lated in early endosomes of cells treated with concana- When cells expressing Ptc1 and wtSmo were incubated
mycin A and ShhN (data not shown). Ptc1/Shh/Smo in chloroquine and ShhN for 90 min, numerous Ptc1/
endosomes were detected in chloroquine-treated (see the Smo vesicles were observed (Figure 6G). However, the
Supplementary Material) and concanamycin A-treated addition of ligand in the presence of chloroquine to cells
cells (data not shown). Shh/Smo vesicles in chlo- expressing Ptc1 in combination with either Smo mutant
roquine-treated cells filled with bulk endocytic tracer resulted in the appearance of vesicles that were only
(see the Supplementary Material), consistent with a late Ptc1. Ptc1 thus shows high, intermediate, and low de-
endosomal character. These results demonstrate that grees of colocalization with wtSmo, SmoM1, and
Ptc1 and Smo are cointernalized in response to ligand SmoM2, respectively, suggesting that the ability of Smo
and are transported together into the late endocytic
to be regulated by Ptc1 correlates with the cotransport
pathway.
of both proteins.
To determine if Smo was normally sorted from Ptc1/
Shh complexes destined for lysosomal degradation, hy-
brid cells were incubated with and without ShhN in the Anti-LBPA Antibodies Block Shh Signaling
presence of leupeptin. In the absence of ligand, Ptc1 Anti-LBPA antibodies provide a very specific tool to
and Smo retained colocalized distributions similar to test the requirement for late endosomal sorting in Shh
those in cells not treated with leupeptin (Figures 5L and signaling. When internalized by bulk endocytosis, anti-
5R), and Ptc1 did not accumulate in lysosomes as it did
LBPA antibodies bind the antigen in late endosomes,
in parental Ptc1HA cells. This finding is consistent with
perturb the morphology of the internal membranes, and
the reduced effect of chloroquine on the Ptc1/Smo dis-
disrupt protein and lipid sorting within the compartmenttribution in the absence of ligand, which together indi-
[26, 27]. Antibodies directed against a glycoprotein,cate that Ptc1 transport is altered in the presence of
such as LAMP-1, enriched in the limiting membrane ofSmo. However, after the addition of ShhN to hybrid cells
late endosomes do not produce these effects. In inter-incubated in leupeptin, colocalization of Ptc1 and Smo
mediate neural plate explants dissected from early chickwas reduced significantly within 30 min and decreased
embryos, exogenous ShhN induces expression of isl1/2continually over time (Figures 5M–5R). As noted most
transcription factors defining developing motor neuronsstrikingly at 3 and 6 hr after ligand addition, Ptc1 accu-
and represses expression of the Pax7 transcription fac-mulated in vesicles (Figures 5P and 5Q) that were LAMP-
tor in neural precursor cells (Figures 7A and 7D). Prein-1 (data not shown), while Smo immunofluorescence
cubation of explants in chicken LAMP-1 antibodies hadadopted a pattern similar to cells expressing Smo alone
no effect on these responses to ShhN (Figures 7B and(Figure 2). In the presence of leupeptin, Shh immunore-
7D). However, preincubation of explants with anti-LBPAactivity accumulated in a pattern virtually identical to
antibodies nearly abolished isl1/2 induction and Pax7Ptc1 but showed no colocalization with Smo (see the
repression (Figures 7C and 7D). ShhN-induced develop-Supplementary Material). Analysis of Ptc1 and Smo pro-
ment of floor plate cells expressing the transcriptiontein levels by immunoblot indicated that Smo was not
factor HNF3was also blocked by anti-LBPA antibodiesdegraded in the presence of ShhN (see below). In addi-
(Figure 7D). Preadsorption of anti-LBPA hybridoma su-tion, Smo was consistently detected on the cell surface
pernatant with protein A-agarose markedly reduced itswith N-terminal antibodies (data not shown). Given the
ability to inhibit HNF3 (Figure 7D) and isl1/2 inductionconstraints arising from the intracellular epitope on
(data not shown), demonstrating that Shh-inhibitory ac-Ptc1HA, colocalization of Ptc1 and Smo in the plasma
tivity resides with the antibody and not another hybrid-membrane could not be determined.
oma-associated factor. Anti-LBPA hybridoma superna-
tant did not interfere with the generation of HNK1Sensitivity of Activated Smo Mutants to Ptc1
migratory neural crest cells in explants (data not shown),Inhibition Correlates with Ptc1 Colocalization
indicating that anti-LBPA does not generally inhibit cel-We determined the distributions of SmoM1 and SmoM2
in hybrid cells also expressing Ptc1. There was essen- lular differentiation. We also tested the effects of anti-
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Figure 6. Smo Mutants Show Differential
Colocalization with Ptc1 and Are Not Co-
transported with Ptc1 in Response to Ligand
gD-SmoF cells and clonal lines expressing
gD-SmoM1 and gD-SmoM2 were fused with
Ptc1HA cells, allowed to recover for 7 hr, in-
cubated in 100 M chloroquine with or with-
out ShhN for 90 min, then fixed and analyzed
for Ptc1 (green) and Smo/M1/M2 immunfluor-
escence (red).
(A–C) Untreated cells fixed 8.5 hr after fusion.
(D–F) Cells treated with chloroquine alone.
Unfilled arrowheads indicate Ptc1/SmoM2
vesicles.
(G–I) Cells treated with chloroquine plus
ShhN. Filled arrowheads indicate Ptc1/
Smo vesicles; unfilled arrowheads indicate
Ptc1/SmoM1/M2 vesicles.
The scale bars represent 10 m.
Figure 7. Anti-LBPA Antibodies Inhibit Shh
Signaling
(A–D) Pax7 repression and isl1/2 induction
in intermediate neural plate explants treated
with (A) 2 nM ShhN alone, (B) preincubated
with anti-chicken LAMP-1 antibody (LAMP)
followed by 2 nM ShhN, and (C) preincubated
with anti-LBPA antibody (LBPA) followed by
ShhN. Pax7 and isl1/2 nuclei are shown as
red and green immunofluorescence, respec-
tively. Because Pax7 is detected with a
mouse monoclonal, explants treated with
anti-LAMP-1 and anti-LBPA show punctate
red fluorescence due to those internalized
mouse antibodies. The scale bar represents
50 m. Data are quantified in (D). Values rep-
resent mean and SEM of positive nuclei
counted within at least nine explants for each
treatment. Control explants were treated with
ShhN alone in supplemented Neurobasal me-
dium (see the Experimental Procedures in the
Supplementary Material available with this ar-
ticle online). Explants incubated without
ShhN showed no isl1/2 or HNF3 cells and
were entirely Pax7 (data not shown). ProtA,
protein A-agarose.
(E–G) Immunofluorescent analysis of Smo
(red) and internalized ShhN (green) in KNRK
cells. Ptc1HA and SmoF cells were fused with
PEG, allowed to recover for 5 hr, then prein-
cubated (E) without or with (F) 1 mM leupeptin
for 1 hr or (G) anti-LBPA hybridoma superna-
tant for 4 hr prior to the addition of ShhN and
6 hr further incubation. The cell in (E) was
identified as a hybrid by triple labeling for
Ptc1, Smo, and Shh; the Ptc1 channel is not
shown. n, nucleus. The scale bar represents
10 m.
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LBPA antibodies on Shh signaling in mouse C3H10T1/2 identical levels of Ptc1 expression but significantly dif-
ferent levels of Smo (Figure 8C). Immunofluorescentcells, which differentiate along a bone/cartilage lineage
and express alkaline phosphatase in response to ShhN. analysis showed population-wide differences in Smo
levels, rather than the presence of Ptc/Smo cells (dataPreincubation of C3H10T1/2 cells with anti-LBPA anti-
bodies resulted in a 65% reduction in alkaline phospha- not shown). In a clone expressing comparable total lev-
els of Ptc1 and Smo, both were detected on the celltase cells after 60 hr of exposure to ShhN, whereas
antibodies against murine LAMP-1 had no effect (data surface at similar levels (Figure 8C, lanes 1 and 5). In
total lysates, Smo appeared in forms ranging from 80not shown). These data demonstrate that functional late
endosomes, more specifically, their internal membranes to 100 kDa, with a very minor fraction above 150 kDa
(Figures 8B, lane 4, and 8C); however, a single bandand the capacity for sorting cargo, are required for nor-
mal Shh signal transduction. close to the predicted size appeared both in immunopre-
cipitates (Figure 8A) and at the cell surface (Figure 8C,To assess the effects of anti-LBPA antibodies on the
transport of Shh, Ptc1, and Smo, we used the cell fusion lane 5). Finally, Smo levels were stable in the presence
of ShhN and cycloheximide, and the migration of Smoassay described above. When hybrid cells were preincu-
bated in leupeptin then treated with ShhN for 6 hr (Figure was unaltered by ShhN (Figure 8A, lane 6 versus lane 7).
7F), we observed Shh vesicles in a pattern identical to
that observed for Ptc1 under these conditions (see Fig- Discussion
ure 5Q). However, Smo did not colocalize with internal-
ized ShhN and appeared predominantly in juxtanuclear Three basic problems in Hedgehog signal transduction
tubulovesicular structures. Cells incubated in ShhN can be addressed with our data: the nature of the Ptc/
alone accumulated little internalized ShhN due to rapid Smo interaction, how the Ptc/Smo relationship is influ-
degradation (Figure 7E). In contrast, when hybrid cells enced by intrinsic properties of each protein, and the
were preincubated with anti-LBPA antibodies, internal- role of endocytic transport in the regulation of Smo activ-
ized ShhN accumulated in the juxtanuclear region, colo- ity by Ptc.
calizing with Smo (Figure 7G).
The Nature of the Ptc/Smo Interaction
and the Proteins’ Intrinsic PropertiesPtc1 Does Not Regulate Smo Protein Levels
in KNRK Cells, and Immunoprecipitable In the absence of Smo, Ptc1 is continuously transported
to late endosomes via the cell surface. In contrast, Smo,Ptc1/Smo Complexes Are Not Detected
The simplest interpretation of the results so far is that in the absence of Ptc1, is abundant at the cell surface,
undergoes a lower rate of endocytosis, and might followPtc1 and Smo form a complex that dissociates after
ligand binding. However, using a variety of approaches, the early endosomal recycling pathway typical for G
protein-coupled receptors [37]. When Ptc1 and Smo areincluding transient fusion of Ptc1HA cells with gD-SmoF
cells or transient transfection of Smo into Ptc1HA cells combined, the rate of Ptc1 internalization is markedly
reduced compared to its rate when expressed alone,(data not shown), and selection of stable Ptc1/Smo hy-
brids after fusion (Figure 8), we were unable to demon- and Ptc1 and Smo appear together in endosomes at a
slow rate. However, Shh causes Ptc1 and Smo to appearstrate immunoprecipitable Ptc1/Smo complexes in
KNRK cells. Using a population in which about half the simultaneously in endosomes at a much higher rate,
closer to that of Ptc1 alone. Nevertheless, Ptc1 and Smocells expressed both proteins, immunoprecipitation of
either Ptc1 (Figure 8A, lanes 1–5) or Smo (Figure 8A, become dramatically segregated simply by the addition
of ligand, but only after transport into endosomes. Smolanes 6–10) failed to demonstrate Ptc1/Smo binding. In
a clonal line with95% of cells expressing both proteins appears to be segregated from Ptc1 only under two
conditions: in the presence of Shh (and normal endo-(Figure 8A, lanes 11–13), immunoprecipitation of Smo
via either the N or C terminus or Ptc1 failed to demon- cytic transport), or when bearing an activating mutation,
as in the case of SmoM1 and SmoM2. The simpleststrate Ptc1/Smo binding. It is unlikely that we failed to
detect complexes due to association with Triton X-100- interpretation of the confocal data is that Ptc1 and Smo
do form a complex and that the Shh-induced release ofinsoluble rafts: differential centrifugation showed that
both Ptc1 and Smo are nearly completely solubilized by Smo inhibition reflects dissociation of Smo from Ptc
after internalization. However, this simple model is notcold Triton X-100 (Figure 8B, lanes 1–6). We did find that
a significant fraction of Ptc1 was insoluble in another supported by our biochemical data.
So far, all the studies demonstrating Ptc/Smo coim-nonionic detergent, Lubrol WX (Figure 8B, lanes 7–8).
The insolubility of Ptc1 in Lubrol WX was unaffected by munoprecipitation used COS or 293 cells transiently
transfected with both constructs [3, 6, 7, 38]. In at leastlysis in high-ionic strength buffer (1 M NaCl) or pretreat-
ment of cells with 1 M cytochalasin D to disrupt actin some of these studies, the Ptc/Smo complex was deter-
mined to represent only 30% of the total of each proteinfilaments (data not shown), discounting cytoskeletal as-
sociations. [3], and, in all cases, the forms of Smo detected in the
immunoprecipitates ran at very high molecular weights,We selected the cells stably expressing Ptc1 and Smo
by fusing a mixed population expressing various levels possibly representing multimers (resistant to SDS and
reducing agents). Using the same constructs in stableof gD-SmoF with a clonal line expressing Ptc1HA homo-
geneously (see the Experimental Procedures in the Sup- cell lines producing lower protein levels, we find no
evidence of immunoprecipitable Ptc1/Smo complexesplementary Material available with this article online).
Subsequently, isolated clones all showed essentially but also do not observe high-molecular weight forms of
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Figure 8. Biochemical Analysis of Stably
Coexpressed Ptc1 and Smo
(A) Immunoprecipitation of Ptc1 and Smo.
Lanes 1–5 are Ptc1 immunoprecipitations
with anti-HA, lanes 6–10 are Smo immunopre-
cipitations with anti-gD. The Ptc1 Western
(anti-HA) is at top, and the Smo Western (anti-
gD) is at the bottom. Migration of molecular
weight standards is at the right. Lanes 1 and
6, uncloned population of PtcSmo cells; lanes
2 and 7, uncloned PtcSmo cells treated with
ShhN and cycloheximide for 6 hr; lanes 3 and
8, coculture of parental Ptc1HA cells mixed
with gD-SmoF cells; lanes 4 and 5, Ptc1HA
cells; lanes 5 and 10, gD-SmoF cells. Faint
background bands are visible in the Ptc
Western, lanes 6–10. Lanes 11–13 are immu-
noprecipitations from PtcSmo cell clone B24
(see [C]), using anti-HA for Ptc1 (lane 11) and
either anti-gD (lane 12) or anti-Flag (lane 13)
for Smo. A single blot was cut, Ptc1 was de-
tected in the top portion (anti-HA), and Smo
was detected in the bottom (anti-gD).
(B) Analysis of detergent solubility of Ptc1
and Smo alone and when coexpressed. Dif-
ferential extraction in cold versus warm Triton
X-100 and Lubrol WX is described in the Ex-
perimental Procedures; only cold prepara-
tions are shown. Samples were the entire pel-
let (pel) and 1.5% (lanes 2, 4, and 6) or 5%
(lane 8) of the supernatant (sup). Lanes 1–6
represent cold Triton extracts; (lanes 1–2)
Ptc1 extracted from Ptc1HA cell line 2D6;
(lanes 3–4) Smo extracted from gD-SmoF
cells; (lanes 5–6) both proteins extracted from
PtcSmo cell clone B24 derived from fusion of
the two former. In lanes 5–6, the blot was cut
to analyze Ptc1 (anti-HA) and Smo (anti-gD)
in the same protein load. Lanes 7–8, Ptc1
extracted from line 2D6 with cold Lubrol WX.
(C) Analysis of Ptc1 and Smo levels in four
clonal PtcSmo cell lines. Lanes 1–4 represent
total protein in Triton X-100 extracts prepared from equal numbers of cells, and the blot was cut to detect Ptc1 (anti-HA) and Smo (anti-gD)
in the same protein loads. Lane 5, cell surface biotinylated Ptc1 and Smo from the clone in lane 1.
Smo. In spite of this, it seems clear from the high degree Smo, prevents its accumulation at the cell surface, or
directly alters its phosphorylation state.of colocalization (much greater than 30% of the total
signal for each) and cotransport that Ptc1 and Smo must
have some form of intimate relationship that is disrupted The Role of Endocytic Transport in the Regulation
of Shh Signal Transductionby ligand or mutation.
Our biochemical analysis sheds considerable light on In most signal transduction pathways, ligand-activated
receptors typically are downregulated through late en-the relationship of intrinsic properties of Ptc1 to regula-
tion of Smo. In Hh-responsive cells in Drosophila, Ptc dosomal targeting. However, Hh signaling is unique in
that the ligand binding component is an inhibitor withoutappears to regulate the overall abundance of Smo and
both levels and phosphorylation state at the cell surface signaling activity. Agents that block Shh signaling in-
clude the steroidal alkaloid cyclopamine, progesterone,[10, 12]. In KNRK cells, which appear to lack a functional
Hh response (unpublished data), a wide range of Smo the synthetic steroid U18666A, chloroquine [17, 39, 40],
and now anti-LBPA antibodies. All of these agents alsolevels were achieved in the presence of a set level of
Ptc1, and in a clone with similar total levels of both induce cellular phenocopies of NPC1 mutations, and
many have well-described effects on late endosomalproteins, both were found on the cell surface at nearly
the same degree. In total lysates, Smo presented as functions. These studies produce a quandary: do the
agents block signaling by enhancing the inhibitory activ-several bands with small differences in migration, possi-
bly indicative of phosphorylation. However, the nature ity of Ptc, which is known to enter late endocytic com-
partments? Or do they somehow impair the ability ofand significance of these forms remains questionable
since they were generally absent from immunoprecipi- Smo to generate a signal? Why would Smo, a G protein-
coupled receptor family member, require functional latetates and the cell surface pool, and their abundance
was not altered by Shh. These data indicate that Ptc1 endosomes to signal? Signaling by Frizzled, the Smo-
related Wingless receptor, is actually enhanced by chlo-does not possess an intrinsic activity that destabilizes
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roquine [41], presumably due to a failure to degrade tant to Ptc, as suggested by the activated Smo mutants
and Hh-induced Smo phosphorylation. This is achievedactive Wingless/Frizzled complexes. Our studies resolve
the quandary by showing that both Ptc and Smo enter under normal conditions by ligand binding, internaliza-
tion of Smo into endosomes along with Ptc/Hh com-the endocytic pathway together after ligand binding but
are subsequently segregated. The Shh-induced endo- plexes, then sorting of Smo from Ptc/Hh complexes
by a process that requires endosomal acidification andsomal accumulation of Ptc1 and Smo in the presence
of chloroquine and the failure of internalized Shh to intact LBPA-rich membranes. Once Smo becomes
sorted from Ptc/Hh complexes, it could activate signalsegregate from Smo in anti-LBPA-treated cells strongly
suggest that at least some of the agents block Shh transduction upon recycling to a Ptc-free compartment,
where it might interact with second messenger ef-signaling by preventing the segregation of Smo from
Ptc1. Release of Smo inhibition may involve both degra- fectors. Thus, late endosomes are not required for signal
transduction per se, but to provide the mechanism fordation of Ptc and sorting of Smo within late endosomes,
the latter requiring functional LBPA-rich membranes. generating active Smo in a ligand-dependent manner.
The proximity requirement for inhibition of Smo by PtcThese findings, along with our results with the activated
Smo mutants, strongly suggest that Ptc1 must be in and its apparent catalytic nature suggests that Ptc may
function by continually altering the bilayer or by actingclose proximity to Smo in order to achieve inhibition.
Ptc SSD mutants fail to inhibit Smo but sequester Hh: on a ubiquitous lipid substrate to create a nonpermissive
microenvironment. Once Ptc is removed (genetically orthe mutant proteins still traverse the plasma membrane
to bind Hh with subsequent transport to endosomes by ligand), membranes would become permissive for
Smo activity. Hh binding may thus act to transfer Smo[21, 22]. Ptc trafficking thus appears largely undisturbed,
yet regulation of Smo fails. This indicates that inhibition to a signaling-permissive domain.
This model can explain the distribution of Ptc andof Smo does not require solely endocytic transport of
Ptc, but it also requires an SSD-dependent activity or Smo observed in Drosophila cells. Although Denef and
colleagues observed higher levels of phosphorylatedinteraction. While the basis for Ptc/Smo colocalization
prior to ligand exposure is unclear, the SSD may play a Smo relative to Ptc at the cell surface after stimulation
with Hh, it appeared that nearly equal but low levels ofrole. On the other hand, Ptc SSD mutants also antago-
nize wild-type Ptc, suggesting that they are inactive unphosphorylated Smo and Ptc were at the surface of
unstimulated cells [10]. We suggest that the phosphory-proteins that compete for binding to a factor required
for inhibition of Smo. Since our findings indicate that lation of Smo is not controlled by Ptc directly, but occurs
as Smo enters an environment that is permissive forPtc1 does not regulate Smo intrinsically through desta-
bilization, this raises the possibility that Ptc uses its signaling. The appearance of phosphorylated Smo at
the cell surface occurs in a time frame consistent withSSD to inhibit Smo through modification of membranes,
based on a mechanism similar to that used by NPC1 the involvement of membrane trafficking. Phosphoryla-
tion may secondarily control Smo protein stability and(and requiring its SSD) for maintenance of raft lipid distri-
bution [42]. Both NPC1 and Ptc are related to bacterial thus total Smo levels in stimulated Hh-responsive cells
and could potentially target active Smo to microdomainspermeases [43], and NPC1 can transport fatty acids and
other lipophilic molecules across membranes and out of or a membrane transport pathway that maintains its
segregation from Ptc; for example, by controlling trans-endosomes/lysosomes [44]. The even stronger similarity
of Ptc to bacterial permeases suggests that it is highly cytosis [47]. This could provide a mechanism to achieve
the seemingly paradoxical situation in which high Smolikely to possess a similar activity and raises the possibil-
ity that some inhibitors of Shh signaling might be pump levels are present in cells responding to Hh with high
Ptc expression. The distributions of Ptc and Smo at thesubstrates. Ptc pump activity could work on a ubiquitous
substrate and render membranes impermissible for Smo anterior/posterior border in the Drosophila wing disc
epithelium might thus reflect the transcytosis of acti-signaling, or they could control the bilayer distribution
of a lipid or lipophilic Smo activator or inhibitor. Ptc vated Smo from the apical to basolateral pathway after
Hh-induced internalization from the apical surface,could potentially utilize cholesterol-rich microdomains
for such a function. Although we do not find Ptc1 to be which appears to be the site of Hh binding [48]. Since
basolateral and apical cargo are maintained in distinctassociated strongly with typical Triton-insoluble rafts,
our preliminary studies suggest that Ptc1 associates transport containers, even in nonpolarized cells [49],
and subcellular transport pathways have unique lipidwith Lubrol-insoluble rafts. Lubrol insolubility has been
demonstrated for two proteins that undergo a direct compositions [50, 51], this could maintain Smo signaling
activity in the face of Ptc upregulation.interaction with cholesterol in a novel type of lipid raft
during vesicular transport [45, 46].
Conclusions
In the absence of Shh, Ptc1 and Smo colocalize exten-A Model for Hh Signal Transduction Synthesizing
Vertebrate and Invertebrate Data sively, and both proteins undergo simultaneous trans-
port into the endocytic pathway after ligand binding.A synthesis of our data and that from other systems
provides the basis for the following model: in unstimu- Smo is subsequently segregated from Ptc1/Shh com-
plexes destined for lysosomal degradation. Late endo-lated cells, the inhibition of Smo by Ptc requires that
they be in close proximity, i.e., the same membrane- somal sorting may thus control the ligand-dependent
generation of active Smo, which can then signal inde-bound compartment (including the plasma membrane).
Smo must undergo a state change in order to be resis- pendently from Ptc1. Smo is segregated from Ptc1 only
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lation of smoothened is part of a self- correcting mechanism inby the addition of ligand or by activating mutations. Ptc1
the Hedgehog signaling system. Mol. Cell 6, 457–465.must therefore have close proximity to Smo in order to
13. Johnson, R.L., Milenkovic, L., and Scott, M.P. (2000). In vivoinhibit it. Ptc may perform its dual functions in Hh signal-
functions of the patched protein: requirement of the C terminus
ing by coupling both the release of Smo inhibition and for target gene inactivation but not Hedgehog sequestration.
Hh sequestration to late endosomal transport. Mol. Cell 6, 467–478.
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